Canaccord Genuity Maintains Hold on Repligen, Lowers Price Target to $145

Benzinga Newsdesk www.benzinga.com Negative 89.3%

Neg 89.3% Neu 0% Pos 0%

Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:RGEN) with a Hold and lowers the price target from $165 to $145.